| Jacqueline Shannon Keselman, | |
|
1336 Bristol Pike Ste 100, Bensalem, PA 19020-5670 | |
| (215) 638-7135 | |
| Not Available |
| Full Name | Jacqueline Shannon Keselman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1336 Bristol Pike Ste 100, Bensalem, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215543574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP454796 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Shannon Keselman, 25 W Bellwood Dr, Holland, PA 18966-1753 Ph: () - | Jacqueline Shannon Keselman, 1336 Bristol Pike Ste 100, Bensalem, PA 19020-5670 Ph: (215) 638-7135 |
News Archive
Most people are rather vague when reporting on food and drink consumption, smoking and exercise habits. General practitioners, however, are skilled at interpreting phrases such as "I only have a few drinks rarely...each week" and "I get to the gym regularly" and can estimate based on symptoms and a person's physical appearance just how precise those claims are. However, it is crucial for healthcare research and epidemiology that relies on patient self-reporting that we find a more objective, rather than intuitive, way to identify bias in self-reporting.
Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter ended June 30, 2009. All results are reported in Canadian dollars unless otherwise stated.
According to the article, type 2 diabetes and hypertension are often associated. At age 40, approximately 32 percent of patients with type 2 diabetes are also hypertensive, and that proportion increases to 47 percent by age 60, the article states.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
› Verified 4 days ago
Dr. Rishit R Patel, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 Fulton Cir, Bensalem, PA 19020 Phone: 215-850-7820 | |
Eunice Eunmi Park, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2301 Bristol Rd, Bensalem, PA 19020 Phone: 215-741-9772 | |
Dr. Loredana Marzullo Shapson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Rock Hill Dr, Bensalem, PA 19020 Phone: 215-364-9630 | |
Michael Huynh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Rock Hill Dr, Bensalem, PA 19020 Phone: 215-364-9630 | |
Mrs. Mariamma Mathew, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1417 Berkshire Dr, Bensalem, PA 19020 Phone: 267-255-7444 | |
Dr. Megan Kunzig, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Rock Hill Dr, Bensalem, PA 19020 Phone: 215-364-9630 | |
Jessica Lee Spiller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2721 Street Rd, Bensalem, PA 19020 Phone: 215-604-1390 |